Treatment options in Huntington's disease

被引:0
作者
Lopez-Sendon Moreno, Jose Luis [1 ,3 ]
Garcia de Yebenes, Justo [2 ,3 ]
机构
[1] Hosp Ramon & Cajal, Serv Neurol, E-28034 Madrid, Spain
[2] Fdn Invest Neurol, Colmenar Viejo, Spain
[3] Inst Salud Carlos III, CIBERNED, Madrid, Spain
关键词
genetic intervention; Huntington's disease; neuroprotective treatment; neurorestorative treatment; preimplantation diagnosis; symptomatic treatment; DEEP BRAIN-STIMULATION; DOPAMINERGIC STABILIZER; EMOTION RECOGNITION; CLINICAL-TRIALS; TRACK-HD; CHOREA; ONSET; SAFETY; PROGRESSION; MANAGEMENT;
D O I
10.1517/21678707.2013.851598
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Huntington's disease (HD) is a progressive neurodegenerative disorder caused by an expanded CAG repeat expansion located in the huntingtin gene. It is characterized by motor, cognitive, and psychiatric disturbances that hinder quality of life and lead to death two decades after onset. As in many low-prevalence diseases, no statement can be made regarding best symptomatic, restorative, or protective medical treatment in terms of evidence-based medicine. Most recommendations are, therefore, based on expert opinion and standard clinical practice. Areas covered: This review covers papers published on the treatment of HD in public databases as well as clinical trials performed in this disease. Symptomatic, neuroprotective, and neurorestorative treatments are discussed as well as genetic interventions. Recent advances in our understanding of the molecular biology of the HD gene and the availability of detectable biomarkers years before disease onset, coupled with the existence of worldwide study groups, form a promising scenario for the development of disease-modifying interventions and symptomatic treatments. Expert opinion: There is no evidence for effective neuroprotective or neurorestorative therapy in HD but some symptomatic treatment may provide at least partial relief of symptoms and genetic intervention could prevent disease transmission.
引用
收藏
页码:901 / 914
页数:14
相关论文
共 98 条
[1]   Symptomatic treatment of Huntington disease [J].
Adam, Octavian R. ;
Jankovic, Joseph .
NEUROTHERAPEUTICS, 2008, 5 (02) :181-197
[2]   A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease [J].
Almqvist, EW ;
Bloch, M ;
Brinkman, R ;
Craufurd, D ;
Hayden, MR .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (05) :1293-1304
[3]  
[Anonymous], 2009, Med Lett Drugs Ther, V51, P7
[4]  
Antoniades CA, METHODS MOL BIOL, V1010, P19
[5]   Motor and cognitive improvements in patients with Huntington's disease after neural transplantation [J].
Bachoud-Lévi, A ;
Rémy, P ;
Nguyen, JP ;
Brugières, P ;
Lefaucheur, JP ;
Bourdet, C ;
Baudic, S ;
Gaura, V ;
Maison, P ;
Haddad, B ;
Boissé, MF ;
Grandmougin, T ;
Jény, R ;
Bartolomeo, P ;
Dalla Barba, G ;
Degos, JD ;
Lisovoski, F ;
Ergis, AM ;
Pailhous, E ;
Cesaro, P ;
Hantraye, P ;
Peschanski, M .
LANCET, 2000, 356 (9246) :1975-1979
[6]   Effect of fetal neural transplants inpatients with Huntington's disease 6 years after surgery:: a long-term follow-up study [J].
Bachoud-Lévi, AC ;
Gaura, V ;
Brugières, P ;
Lefaucheur, JP ;
Boissé, MF ;
Maison, P ;
Baudic, S ;
Ribeiro, MJ ;
Bourdet, C ;
Remy, P ;
Cesaro, P ;
Hantraye, P ;
Peschanski, M .
LANCET NEUROLOGY, 2006, 5 (04) :303-309
[7]   Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease [J].
Bachoud-Lévi, AC ;
Bourdet, C ;
Brugières, P ;
Nguyen, JP ;
Grandmougin, T ;
Haddad, B ;
Jény, R ;
Bartolomeo, P ;
Boissé, MF ;
Dalla Barba, G ;
Degos, JD ;
Ergis, AM ;
Lefaucheur, JP ;
Lisovoski, F ;
Pailhous, E ;
Rémy, P ;
Palfi, S ;
Defer, GL ;
Cesaro, P ;
Hantraye, P ;
Peschanski, M .
EXPERIMENTAL NEUROLOGY, 2000, 161 (01) :194-202
[8]   The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease [J].
Barker, Roger A. ;
Mason, Sarah L. ;
Harrower, Timothy P. ;
Swain, Rachel A. ;
Ho, Aileen K. ;
Sahakian, Barbara J. ;
Mathur, Raj ;
Elneil, Sohier ;
Thornton, Steven ;
Hurrelbrink, Carrie ;
Armstrong, Richard J. ;
Tyers, Pam ;
Smith, Emma ;
Carpenter, Adrian ;
Piccini, Paola ;
Tai, Yen F. ;
Brooks, David J. ;
Pavese, Nicola ;
Watts, Colin ;
Pickard, John D. ;
Rosser, Anne E. ;
Dunnett, Stephen B. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (06) :657-665
[9]   Cellular Therapy and Induced Neuronal Replacement for Huntington's Disease [J].
Benraiss, Abdellatif ;
Goldman, Steven A. .
NEUROTHERAPEUTICS, 2011, 8 (04) :577-590
[10]   Buspirone in the management of disruptive behaviors due to Huntington's disease and other neurological disorders [J].
Bhandary, AN ;
Masand, PS .
PSYCHOSOMATICS, 1997, 38 (04) :389-391